中文 | English
Return
Total: 17 , 1/2
Show Home Prev Next End page: GO
Author:(Mingyi LUO)

1.Exploration on the Effects of Bushen Huoxue Prescription on Rabbit Intervertebral Disc Degeneration Based on the RIPK1/RIPK3/MLKL Signaling Pathway

Wei PENG ; Liguo ZHU ; Xunlu YIN ; Jie LUO ; Kexin YANG ; Minshan FENG ; Jie YU ; Long LIANG ; Linghui LI ; Jiawen ZHAN ; Tao HAN ; Mingyi LUO ; Dian ZHANG

Chinese Journal of Information on Traditional Chinese Medicine 2025;32(2):71-77

2.Exploration on the Effect of Bushen Huoxue Prescription on Necroptosis in Human Nucleus Pulposus Cells Based on RIPK1/RIPK3/MLKL Pathway

Wei PENG ; Liguo ZHU ; Xunlu YIN ; Kexin YANG ; Jie LUO ; Minshan FENG ; Jie YU ; Linghui LI ; Jiawen ZHAN ; Tao HAN ; Long LIANG ; Mingyi LUO ; Dian ZHANG

Chinese Journal of Information on Traditional Chinese Medicine 2025;32(3):69-75

3.Association between edentulism and the risk of social isolation in middle-aged and older adults

DUAN Chengwei ; LUO Mingyi ; FAN Chenrui ; XU Jialei ; MUHETAER Tureke ; XU Mengyuan ; WAN Weiping ; LIAO Haiqing ; WU Zeni

Journal of Prevention and Treatment for Stomatological Diseases 2025;33(12):1070-1077

4.Exploration on the Effects of Bushen Huoxue Prescription on Rabbit Intervertebral Disc Degeneration Based on the RIPK1/RIPK3/MLKL Signaling Pathway

Wei PENG ; Liguo ZHU ; Xunlu YIN ; Jie LUO ; Kexin YANG ; Minshan FENG ; Jie YU ; Long LIANG ; Linghui LI ; Jiawen ZHAN ; Tao HAN ; Mingyi LUO ; Dian ZHANG

Chinese Journal of Information on Traditional Chinese Medicine 2025;32(2):71-77

5.Exploration on the Effect of Bushen Huoxue Prescription on Necroptosis in Human Nucleus Pulposus Cells Based on RIPK1/RIPK3/MLKL Pathway

Wei PENG ; Liguo ZHU ; Xunlu YIN ; Kexin YANG ; Jie LUO ; Minshan FENG ; Jie YU ; Linghui LI ; Jiawen ZHAN ; Tao HAN ; Long LIANG ; Mingyi LUO ; Dian ZHANG

Chinese Journal of Information on Traditional Chinese Medicine 2025;32(3):69-75

6.Early Onset Pulmonary Events and Management Strategies during the Treatment of 
ALK Positive NSCLC Patients with Brigatinib.

Mingyi YANG ; Weichi LUO ; Qing ZHOU

Chinese Journal of Lung Cancer 2023;26(4):281-290

7.Mechanism of mitochondrial dysfunction in the development of nonalcoholic fatty liver disease

Zixin XU ; Shengzheng LUO ; Mingyi XU

Journal of Clinical Hepatology 2020;36(10):2353-2355

8.Mechanism of action of microRNA-27a in the development and progression of liver diseases

Xin LUO ; Mingyi XU

Journal of Clinical Hepatology 2020;36(7):1666-1668

9.An in vitro study of zinc-alpha-2-glycoprotein inhibits activation and proliferation of hepatic stellate cells

Shengzheng LUO ; Juncheng WU ; Renkun LIN ; Ting LIU ; Xin LUO ; Mingyi XU ; Chuanyong GUO

Chinese Journal of Hepatology 2020;28(2):135-140

10.Surgical treatment of hepatic hemangiomas: a study of 908 patients

Xun WANG ; Mingyi CHEN ; Yongwei CHEN ; Ying LUO ; Wenbin JI ; Jing WANG ; Xiaoqiang HUANG ; Yuquan FENG ; Wenzhi ZHANG ; Wanqing GU ; Shichun LU

Chinese Journal of Hepatobiliary Surgery 2018;24(7):442-445

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 17 , 1/2 Show Home Prev Next End page: GO